• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Response Questions for Teleconference Email, July 12, 2010 - Anascorp

Our responses to your questions for July 15 teleconFrom: -----(b)(4)-------
-----(b)(4)-------
Sent: Monday, July 12, 2010 7:13 PM
To: Cordaro, Debbie
Subject: RE: Our responses to your questions for July 15 telecon

Hi Debbie:
Thanks very much for the Agency’s responses.  We have looked them over and still
would like to talk with the Agency.
Thanks for your help and quick response.
(b)(4)
 
-------(b)(4)---------
-(b)(4)-
-----(b)(4)-------
-----(b)(4)-------
-----(b)(4)-------
-----(b)(4)-------
-----(b)(4)-------
 



From: Cordaro, Debbie [mailto:Debbie.Cordaro@fda.hhs.gov]
Sent: Monday, July 12, 2010 2:18 PM
To: ----(b)(4)----
Cc: ----(b)(4)----
Subject: Our responses to your questions for July 15 telecon
 
<<Bioclon CRMTS 7517 Meeting Responses Fax.pdf>>
Hi (b)(4),
FDA is providing their responses to the questions you posed for our meeting
Thursday.  Please let me know your decision regarding changing the agenda.
Have a nice day,
Debbie
 
Debbie Cordaro
Debbie Cordaro
Regulatory Project Manager
OBRR
Voice: 301-827-6157 Fax 301-827-2857
debbie.cordaro@fda.hhs.gov

 

__________ Information from ESET NOD32 Antivirus, version of virus signature
database 5273 (20100712) __________

The message was checked by ESET NOD32 Antivirus.

http://www.eset.com/


__________ Information from ESET NOD32 Antivirus, version of virus signature
database 5273 (20100712) __________

The message was checked by ESET NOD32 Antivirus.

http://www.eset.com/